Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Apple
AAPL
|
+$279M |
| 3 |
iShares Short Treasury Bond ETF
SHV
|
+$255M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$250M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$249M |
Top Sells
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$412M |
| 2 |
Automatic Data Processing
ADP
|
+$377M |
| 3 |
AABA
Altaba Inc. Common Stock
AABA
|
+$306M |
| 4 |
Meta Platforms (Facebook)
META
|
+$299M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$275M |
Sector Composition
| 1 | Financials | 10.38% |
| 2 | Technology | 10.31% |
| 3 | Consumer Discretionary | 6.95% |
| 4 | Energy | 6.58% |
| 5 | Healthcare | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
SPDR Portfolio TIPS ETF
SPIP
$988M
| $1M | ﹤0.01% |
36,086
-36,030
| -50% | -$1M |
|
1827
Openlane
KAR
$3.07B
| $1M | ﹤0.01% |
48,261
-19,303
| -29% | -$400K |
|
1828
Vanguard International High Dividend Yield ETF
VYMI
$12B
| $1M | ﹤0.01% |
16,082
+7,096
| +79% | +$442K |
|
|
MDSO
1829
DELISTED
Medidata Solutions, Inc.
MDSO
| $998K | ﹤0.01% |
12,384
+535
| +5% | +$43.1K |
|
|
MITL
1830
DELISTED
Mitel Networks Corporation
MITL
| $995K | ﹤0.01% |
90,721
+90,391
| +27,391% | +$991K |
|
1831
Applied Optoelectronics
AAOI
$1.69B
| $991K | ﹤0.01% |
22,091
+18,060
| +448% | +$810K |
|
1832
CytomX Therapeutics
CTMX
$330M
| $988K | ﹤0.01% |
43,228
+11,505
| +36% | +$263K |
|
1833
Allegion
ALLE
$15B
| $985K | ﹤0.01% |
12,723
+1,939
| +18% | +$150K |
|
1834
Ambev
ABEV
$35.9B
| $984K | ﹤0.01% |
212,427
-115,033
| -35% | -$533K |
|
1835
Tri Pointe Homes
TPH
$3.09B
| $983K | ﹤0.01% |
60,022
+5,156
| +9% | +$84.4K |
|
|
CET
1836
Central Securities Corp
CET
$1.47B
| $982K | ﹤0.01% |
35,239
-8,333
| -19% | -$232K |
|
1837
Deluxe
DLX
$881M
| $982K | ﹤0.01% |
14,831
+6,556
| +79% | +$434K |
|
1838
Novavax
NVAX
$1.3B
| $982K | ﹤0.01% |
36,666
-9,634
| -21% | -$258K |
|
1839
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
| $979K | ﹤0.01% |
50,810
+6,400
| +14% | +$123K |
|
1840
Genesco
GCO
$358M
| $978K | ﹤0.01% |
24,646
-8,254
| -25% | -$328K |
|
1841
TTEC Holdings
TTEC
$173M
| $978K | ﹤0.01% |
28,312
-1,337
| -5% | -$46.2K |
|
|
CPE
1842
DELISTED
Callon Petroleum Company
CPE
| $977K | ﹤0.01% |
9,104
-37,956
| -81% | -$4.07M |
|
1843
Global X Robotics & Artificial Intelligence ETF
BOTZ
$2.88B
| $976K | ﹤0.01% |
44,321
-608
| -1% | -$13.4K |
|
1844
Integra LifeSciences
IART
$1.17B
| $976K | ﹤0.01% |
15,160
+4,161
| +38% | +$268K |
|
|
ORIT
1845
DELISTED
Oritani Financial Corp. New
ORIT
| $976K | ﹤0.01% |
60,299
+47,574
| +374% | +$770K |
|
1846
iShares US Technology ETF
IYW
$24B
| $972K | ﹤0.01% |
21,812
+2,864
| +15% | +$128K |
|
|
GTHX
1847
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $969K | ﹤0.01% |
22,301
+20,318
| +1,025% | +$883K |
|
1848
Sprouts Farmers Market
SFM
$13.3B
| $968K | ﹤0.01% |
43,834
-258
| -0.6% | -$5.7K |
|
|
RPT
1849
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $963K | ﹤0.01% |
72,872
+3,374
| +5% | +$44.6K |
|
|
MNTA
1850
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $963K | ﹤0.01% |
47,113
-18,071
| -28% | -$369K |
|